Grid.ID Reporter, Novia Tri Astuti
Grid.ID – Lately, the ranks of the Government in the country are intensively boosting the vaccination program covid-19.
Not without reason, this is intended so that people in the country are immediately free from the virus covid-19.
Well, if there was before Sinovac, Sinopharm and several types of vaccines that are so familiar.
Recently, the Food and Drug Administration issued an emergency use authorization (EUA) for the Pfizer type vaccine on July 14, 2021.
Reported from Kompas.com, Sunday (18/7/2021), the results of the 3rd phase clinical trial from Pfizer vaccine it has efficacy reach 100 percent.
However, this figure is for the 12-15 year age group.
Meanwhile, for those aged 16 years and over, the efficacy has decreased to 95.5 percent.
“And the phase III clinical trial data shows the efficacy of comirnaty, at the age of 16 years and over is 95.5 percent and at the age of 12-15 years is 100 percent,” said Penny in a virtual press conference, Thursday (15/7/2021 ).
With the issuance of the EUA for the Pfizer vaccine, BPOM has issued an emergency use permit for six types of Covid-19 vaccines in Indonesia.
“First, there is Coronavac from Sinovac, Covid-19 vaccine produced by Bio Farma, AstraZeneca obtained from Covax facility, Sinopharm from Beijing, and Moderna from America,” said Penny.
As is known, the vaccine produced by Pfizer and BioTech is given by injection twice in a span of three weeks.
Yes, from the immunogenicity data, the administration of two doses of the comirnaty vaccine within three weeks of the vaccine produced a good response.
As a result, BPOM stated that several studies showed the safety of the Pfizer vaccine to be tolerated in all age groups.
BPOM also said that the Pfizer vaccine quality data assessment had been carried out in accordance with internationally accepted evaluation guidelines.
Also Read: Can I inject the First and Second Vaccines in Different Locations? Check out the explanation below!
Meanwhile, the side effects of the injection Pfizer vaccine these are pain at the injection site, fatigue, headache, muscle aches, joint pain and fever.
Added from Tribunnews which launched from Malay Mail, Minister of Health Adham said that the state of Kelantan would stop supplying vaccines Sinovac and switched to Pfizer.
In line with that statement, Kelantan Health Director, Dr Zaini Hussin said the vaccine supply Sinovac will be discontinued at the end of July.
“Starting Sunday (18 July), all vaccination centers in Kelantan will only be vaccinated Sinovac The second dose is sufficient,” he said as reported by Harian Metro on Thursday (15/7/2021).
Dr Zaini says that there will be no more first dose of vaccine Sinovac given from July 13.
As is known, the cessation of vaccines sinovac mentioned because the circulating dose has run out.
https://www.youtube.com/watch?v=HntH4eCpZrE
– PROMOTED CONTENT
pfizer vaccine
